COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): SelectMDx Cost-effective in Four European Countries

28/08/2018 - 07:01

NEWS RELEASE REGULATED INFORMATION Cost savings for healthcare providers in France, Germany, Italy and Spain of over €300 million IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 28 August 2018 - MDxHealth SA (Euronext: [...]

MDxHealth (R) : SelectMDx : rapport coût-effectivité positif dans quatre pays européens

28/08/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Une économie potentielle de plus de 300 millions d'euros sur les soins de santé en France, en Allemagne, en Italie et en Espagne IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 [...]

Biocartis Group NV: Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy

28/08/2018 - 07:01

PRESS RELEASE : 28 August 2018, 07:00 CEST Biocartis Obtains Exclusive Worldwide License Rights for EGFR Ectodomain Mutations Determining Response to Targeted Colorectal Cancer Therapy Mechelen, Belgium, 28 August 2018 [...]

Kiadis Pharma to attend upcoming investor conferences in September 2018

28/08/2018 - 07:01

Kiadis Pharma to attend upcoming investor conferences in September 2018 Amsterdam, The Netherlands, August 28, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]

Orphazyme announces Interim Report First Half 2018

28/08/2018 - 07:01

Orphazyme A/S Company announcement No. 11/2018 Company Registration No. 32266355 The first part of 2018 has taken Orphazyme further along the path of bringing arimoclomol to rare disease patients in great need of new [...]

Wright Medical Group N.V. Announces Pricing of Public Offering of Ordinary Shares

28/08/2018 - 01:42

AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its [...]

EB Research Partnership and EB Research Foundation Join Forces to Advance Breakthroughs in Epidermolysis Bullosa Research

28/08/2018 - 01:00

The two leading global nonprofits announce a partnership to combine resources to heal EB NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- EB Research Partnership (EBRP), based in New York, and Australian-based EB Research [...]

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

27/08/2018 - 23:14

- In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an 87% reduction in mean monthly attacks vs. placebo (0.26 vs. 1.97, n=27 vs. n=41) - All secondary endpoints were met and included reduction in [...]

Veritas Completes Share Purchase Agreement with 3 Carbon Extractions Inc.

27/08/2018 - 22:59

VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that the Company has completed the [...]

Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA

27/08/2018 - 22:30

CAMBRIDGE, Mass. and CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA) an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), today announced [...]

Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal Infections (cIAI)

27/08/2018 - 22:19

– XERAVA™ Achieved High Clinical Cure Rates in Clinical Trials in Patients with cIAI – – Broad Product Label for Treatment of cIAI – – Commercial Launch Expected in the Fourth Quarter of 2018 – – Conference Call [...]

XBiotech annonce la publication de résultats décisifs sur le rôle potentiel de l'Interleukine-1 alpha dans le risque des crises cardiaques

27/08/2018 - 22:17

Les résultats montrent la capacité de MABp1 (Bermekimab) à bloquer l'activation endothéliale vasculaire par neutrophile in vitro et la thrombose AUSTIN, Texas, 27 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: [...]

Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets

27/08/2018 - 22:10

Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales Heidelberg, Germany, August 27, 2018 - Affimed N.V [...]

Alphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

27/08/2018 - 22:05

CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through [...]

K2M Group Holdings, Inc. to Participate in Two Investor Conferences in September

27/08/2018 - 22:05

LEESBURG, Va., Aug. 27, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]

Editas Medicine Announces Transition of Chief Medical Officer

27/08/2018 - 22:01

CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that its Chief Medical Officer, Gerald Cox, M.D., Ph.D., will be stepping down [...]

Wright Medical Group N.V. Announces Proposed Public Offering of Ordinary Shares

27/08/2018 - 22:01

Offering of $440 Million Ordinary Shares AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the commencement of a registered underwritten public [...]

Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Europe for the Treatment of Mucopolysaccharidosis VII

27/08/2018 - 22:01

Mepsevii, an Enzyme Replacement Therapy, is the First Treatment Approved in the EU for Mucopolysaccharidosis VII NOVATO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]

National Brain Tumor Society Statement on Passing of Sen. John McCain

27/08/2018 - 20:59

Boston, MA , Aug. 27, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society is profoundly saddened to learn of the senator’s passing, and our thoughts immediately go out to his family, friends, staff, colleagues and [...]